Now,ziconotide,with a completely different mechanism of action,targeting N-type calcium channels,is making its market debuts in the US and Europe-milestones that have received remarkably attention.
随着对离子通道与疼痛的深入研究,现已研发出一个具有全新作用机制的肽类药物齐考诺肽(ziconotide),它通过阻断N型钙离子通道而达到镇痛的目的。